Literature DB >> 22307858

Cognitive deficits in Machado-Joseph disease correlate with hypoperfusion of visual system areas.

Pedro Braga-Neto1, Lívia Almeida Dutra, José Luiz Pedroso, André C Felício, Helena Alessi, Ruth F Santos-Galduroz, Paulo Henrique F Bertolucci, Mário Luiz V Castiglioni, Rodrigo Affonseca Bressan, Griselda Esther Jara de Garrido, Orlando Graziani Povoas Barsottini, Andrea Jackowski.   

Abstract

Cognitive and olfactory impairments have previously been demonstrated in patients with spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease (MJD)-SCA3/MJD. We investigated changes in regional cerebral blood flow (rCBF) using single-photon emission computed tomography (SPECT) imaging in a cohort of Brazilian patients with SCA3/MJD. The aim of the present study was to evaluate the correlation among rCBF, cognitive deficits, and olfactory dysfunction in SCA3/MJD. Twenty-nine genetically confirmed SCA3/MJD patients and 25 control subjects were enrolled in the study. The severity of cerebellar symptoms was measured using the International Cooperative Ataxia Rating Scale and the Scale for the Assessment and Rating of Ataxia. Psychiatric symptoms were evaluated by the Hamilton Anxiety Scale and Beck Depression Inventory. The neuropsychological assessment consisted of Spatial Span, Symbol Search, Picture Completion, the Stroop Color Word Test, Trail Making Test (TMT), and Phonemic Verbal Fluency. Subjects were also submitted to odor identification evaluation using the 16-item Sniffin' Sticks. SPECT was performed using ethyl cysteine dimer labeled with technetium-99m. SCA3/MJD patients showed reduced brain perfusion in the cerebellum, temporal, limbic, and occipital lobes compared to control subjects (pFDR <0.001). A significant positive correlation was found between the Picture Completion test and perfusion of the left parahippocampal gyrus and basal ganglia in the patient group as well as a negative correlation between the TMT part A and bilateral thalamus perfusion. The visuospatial system is affected in patients with SCA3/MJD and may be responsible for the cognitive deficits seen in this disease.

Entities:  

Mesh:

Year:  2012        PMID: 22307858     DOI: 10.1007/s12311-012-0354-x

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  52 in total

Review 1.  An emerging concept. The cerebellar contribution to higher function.

Authors:  J D Schmahmann
Journal:  Arch Neurol       Date:  1991-11

2.  Odorant-induced and sniff-induced activation in the cerebellum of the human.

Authors:  N Sobel; V Prabhakaran; C A Hartley; J E Desmond; Z Zhao; G H Glover; J D Gabrieli; E V Sullivan
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

3.  Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n.

Authors:  L B Jardim; M L Pereira; I Silveira; A Ferro; J Sequeiros; R Giugliani
Journal:  Arch Neurol       Date:  2001-06

Review 4.  Diaschisis.

Authors:  J S Meyer; K Obara; K Muramatsu
Journal:  Neurol Res       Date:  1993-12       Impact factor: 2.448

5.  Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study.

Authors:  Anelyssa D'Abreu; Marcondes C França; Clarissa L Yasuda; Bruno A G Campos; Iscia Lopes-Cendes; Fernando Cendes
Journal:  J Neuroimaging       Date:  2011-06-23       Impact factor: 2.486

6.  Machado-Joseph disease of Azorean ancestry in Brazil: the Catarina kindred. Neurological, neuroimaging, psychiatric and neuropsychological findings in the largest known family, the "Catarina" kindred.

Authors:  J Radvany; C H Camargo; Z M Costa; N C Fonseca; E D Nascimento
Journal:  Arq Neuropsiquiatr       Date:  1993-03       Impact factor: 1.420

7.  Olfactory dysfunction in cerebellar ataxia and multiple system atrophy.

Authors:  Michael Abele; Alexander Riet; Thomas Hummel; Thomas Klockgether; Ullrich Wüllner
Journal:  J Neurol       Date:  2003-12       Impact factor: 4.849

8.  Executive and emotional dysfunction in Machado-Joseph disease.

Authors:  Tricia M Zawacki; Janet Grace; Joseph H Friedman; Lewis Sudarsky
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

9.  Expression of expanded polyglutamine protein induces behavioral changes in Drosophila (polyglutamine-induced changes in Drosophila).

Authors:  Yun-Taik Kim; Sang Min Shin; Won Yong Lee; Gyeong-Moon Kim; Dong Kyu Jin
Journal:  Cell Mol Neurobiol       Date:  2004-02       Impact factor: 5.046

Review 10.  Cerebellar information processing and visuospatial functions.

Authors:  Marco Molinari; Maria G Leggio
Journal:  Cerebellum       Date:  2007       Impact factor: 3.648

View more
  14 in total

1.  Consensus paper: radiological biomarkers of cerebellar diseases.

Authors:  Leonardo Baldarçara; Stuart Currie; M Hadjivassiliou; Nigel Hoggard; Allison Jack; Andrea P Jackowski; Mario Mascalchi; Cecilia Parazzini; Kathrin Reetz; Andrea Righini; Jörg B Schulz; Alessandra Vella; Sara Jane Webb; Christophe Habas
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

2.  Psychosis in Machado-Joseph Disease: Clinical Correlates, Pathophysiological Discussion, and Functional Brain Imaging. Expanding the Cerebellar Cognitive Affective Syndrome.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Ary Gadelha; Maura Regina Laureano; Cristiano de Souza Noto; Griselda Jara Garrido; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2016-08       Impact factor: 3.847

3.  Neurophysiological studies and non-motor symptoms prior to ataxia in a patient with machado-joseph disease: trying to understand the natural history of brain degeneration.

Authors:  José Luiz Pedroso; Edson Bor-Seng-Shu; Pedro Braga-Neto; Rodrigo Souza Ribeiro; Márcio Luiz Escorcio Bezerra; Lucila B F do Prado; Ilza Rosa Batista; Helena Alessi; Manoel Jacobsen Teixeira; Gilberto Mastrocola Manzano; Gilmar Fernandes do Prado; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

4.  Cognitive and Psychiatric Evaluation in SYNE1 Ataxia.

Authors:  Maria Thereza Drumond Gama; Pedro Braga-Neto; Livia Almeida Dutra; Helena Alessi; Lilia Alves Maria; Ary Araripe Gadelha; Bruno Bertolucci Ortiz; Ilda Kunii; Silvia Regina Correia-Silva; Magnus R Dias da Silva; Patrick A Dion; Guy A Rouleau; Marcondes Cavalcante França; Orlando G P Barsottini; José Luiz Pedroso
Journal:  Cerebellum       Date:  2019-08       Impact factor: 3.847

5.  Executive dysfunction in patients with spinocerebellar ataxia type 3.

Authors:  Itaru Tamura; Asako Takei; Shinsuke Hamada; Hiroyuki Soma; Michio Nonaka; Sanae Homma; Fumio Moriwaka
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

6.  Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3.

Authors:  Tátila Martins Lopes; Anelyssa D'Abreu; Marcondes Cavalcante França; Clarissa Lin Yasuda; Luiz Eduardo Betting; Adriana Bastos Samara; Gabriela Castellano; Júlio César Somazz; Marcio Luiz Figueredo Balthazar; Iscia Lopes-Cendes; Fernando Cendes
Journal:  J Neurol       Date:  2013-06-18       Impact factor: 4.849

7.  Association between spinocerebellar ataxias caused by glutamine expansion and psychiatric and neuropsychological signals - a literature review.

Authors:  Uanda Cristina Almeida-Silva; Jaime Eduardo Cecílio Hallak; Wilson Marques Júnior; Flávia de Lima Osório
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

8.  The CCAS-scale in hereditary ataxias: helpful on the group level, particularly in SCA3, but limited in individual patients.

Authors:  Sandra Roeske; Dagmar Timmann; Andreas Thieme; Jennifer Faber; Patricia Sulzer; Kathrin Reetz; Imis Dogan; Miriam Barkhoff; Janna Krahe; Heike Jacobi; Julia-Elisabeth Aktories; Martina Minnerop; Saskia Elben; Raquel van der Veen; Johanna Müller; Giorgi Batsikadze; Jürgen Konczak; Matthis Synofzik
Journal:  J Neurol       Date:  2022-04-01       Impact factor: 6.682

9.  A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7.

Authors:  Amy Moriarty; Arron Cook; Helen Hunt; Matthew E Adams; Lisa Cipolotti; Paola Giunti
Journal:  Orphanet J Rare Dis       Date:  2016-06-22       Impact factor: 4.123

10.  The cerebral metabolic topography of spinocerebellar ataxia type 3.

Authors:  Sanne K Meles; Jelmer G Kok; Bauke M De Jong; Remco J Renken; Jeroen J de Vries; Jacoba M Spikman; Aaltje L Ziengs; Antoon T M Willemsen; Harm J van der Horn; Klaus L Leenders; Hubertus P H Kremer
Journal:  Neuroimage Clin       Date:  2018-03-29       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.